Pacira BioSciences (PCRX) Stock Chart & Stock Price History $26.28 -0.45 (-1.68%) As of 03:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Pacira BioSciences Stock Price Performance The Pacira BioSciences (PCRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 79.03%, with a year-to-date return of 39.50%. In the past month, the stock has increased 16.60%, reflecting recent market activity. As of the latest close, Pacira BioSciences traded at $26.73 with a market cap of $1.20 billion and volume of 773,687 shares. Five years ago, the stock traded at $60.51, representing a 56.57% decrease over that period. At the time, it had a market cap of $2.69 billion and a volume of 356,338 shares. Receive PCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-1.46%1 Month Performance+16.60%3 Month Performance-1.72%Year-To-Date Performance+39.50%1 Year Performance+79.03%5 Year Performance-56.57% PCRX Stock Chart for Friday, September, 5, 2025 PCRX Chart by TradingView Pacira BioSciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/04/2025$27.18$26.73-1.66%$27.64$26.52773,687 shs$1.20 billion09/03/2025$27.22$27.18-0.15%$27.64$27.02566,616 shs$1.22 billion09/02/2025$26.67$27.22+2.06%$27.24$26.42800,697 shs$1.22 billion09/01/2025$26.67$26.67$26.95$26.17616,350 shs$1.20 billion08/29/2025$26.85$26.67-0.67%$26.95$26.17616,350 shs$1.20 billion08/28/2025$26.13$26.85+2.76%$27.04$26.01973,124 shs$1.21 billion08/27/2025$25.99$26.13+0.54%$26.90$25.98908,801 shs$1.17 billion08/26/2025$25.36$25.99+2.48%$26.05$25.14483,611 shs$1.17 billion08/25/2025$25.84$25.36-1.86%$25.87$25.33409,853 shs$1.14 billion08/22/2025$25.39$25.84+1.77%$25.94$25.23453,037 shs$1.16 billion Get the Latest News and Ratings for PCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. 08/21/2025$24.99$25.39+1.60%$25.66$24.69412,317 shs$1.14 billion08/20/2025$25.19$24.99-0.79%$25.39$24.97408,951 shs$1.12 billion08/19/2025$24.89$25.19+1.21%$25.22$23.74651,667 shs$1.13 billion08/18/2025$24.78$24.89+0.44%$25.17$24.73866,017 shs$1.12 billion08/15/2025$24.99$24.78-0.84%$25.18$24.56986,681 shs$1.11 billion08/14/2025$25.04$24.99-0.20%$25.35$24.70761,234 shs$1.12 billion08/13/2025$24.81$25.04+0.93%$25.26$24.77764,841 shs$1.13 billion08/12/2025$25.19$24.81-1.51%$25.50$24.60601,122 shs$1.11 billion08/11/2025$25.18$25.19+0.04%$25.48$24.91534,555 shs$1.13 billion08/08/2025$23.77$25.18+5.93%$25.23$23.501.21 million shs$1.13 billion08/07/2025$22.40$23.77+6.12%$24.18$22.381.06 million shs$1.10 billion08/06/2025$22.54$22.40-0.62%$24.00$21.741.57 million shs$1.04 billion08/05/2025$22.94$22.54-1.74%$22.80$21.79902,104 shs$1.04 billion08/04/2025$22.07$22.94+3.94%$23.27$21.701.11 million shs$1.06 billion Related Companies Perrigo Stock Chart Supernus Pharmaceuticals Stock Chart Nektar Therapeutics Stock Chart Omeros Stock Chart Assembly Biosciences Stock Chart Cumberland Pharmaceuticals Stock Chart Eli Lilly and Company Stock Chart Johnson & Johnson Stock Chart AbbVie Stock Chart Merck & Co., Inc. Stock Chart Receive PCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCRX) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
